Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business. The health care giant said Tuesday that it will separate its orthopedics business into ...

Johnson & Johnson is moving forward with a $6.475 billion proposed settlement of tens of thousands of lawsuits alleging that its baby powder and other talc products contain asbestos and cause ovarian ...

Investing.com -- Johnson & Johnson reported third-quarter earnings and revenue above analyst expectations, and announced it plans to spin off its Orthopaedics business. The pharmaceutical giant’s ...